Giardia duodenalis, known historically as Giardia lamblia or Giardia intestinalis, is a flagellated protozoan parasite that colonizes the small intestine of its host. The organism exists in two principal forms during its life cycle: the actively feeding trophozoite, which attaches to the intestinal wall and interferes with nutrient absorption, and the cyst, a hardy, environmentally resistant stage that is shed in feces and can survive for weeks to months in cool, moist conditions. Infection occurs when a susceptible animal or person ingests these cysts, typically through contaminated water, food, soil, grooming behavior, or direct contact with an infected individual. Once inside the intestine, each cyst releases trophozoites that multiply and begin producing new cysts, perpetuating the cycle of transmission.

In cats, Giardia infection can produce a spectrum of clinical outcomes. Some animals remain entirely asymptomatic, silently shedding cysts into their environment while appearing healthy. Others develop diarrhea that may be acute, intermittent, or chronic, often accompanied by weight loss, poor coat quality, and in young kittens, failure to thrive. The parasite damages the microvilli of the intestinal epithelium, disrupting the absorptive surface area and causing malabsorption of fats and fat-soluble vitamins. Because the clinical signs overlap with those of many other feline gastrointestinal conditions, including bacterial overgrowth, dietary intolerance, and infection with other parasites such as Tritrichomonas foetus, definitive diagnosis requires laboratory testing of fecal samples.

The sheer scale of the new analysis is what sets it apart from earlier surveys. Most previous estimates of Giardia prevalence in cats have relied on modest sample sizes drawn from single clinics, shelters, or regions, making it difficult to draw conclusions about the broader population of pet cats across North America. By pooling results from more than 150,000 stool samples, the researchers were able to generate prevalence estimates with far greater statistical confidence and to examine how infection risk varies across demographic categories such as age, sex, and reproductive status. The overall picture that emerges is one of a parasite that is both widespread and unevenly distributed within the feline population.

The demographic patterns identified in the study are particularly instructive. Young cats were found to be at substantially elevated risk compared with adults, a finding consistent with the biology of the parasite and with earlier research. Kittens have immature immune systems, are more likely to be housed in group settings such as catteries or shelters where transmission pressure is high, and engage in behaviors such as grooming themselves and littermates that facilitate fecal-oral transfer of cysts. Male cats and unneutered cats also showed higher infection rates in the analysis. The association with reproductive status may reflect differences in husbandry, since unneutered animals are more likely to roam outdoors or live in multi-cat breeding environments where parasite recycling is more intense, while sex differences could relate to roaming behavior and exposure to contaminated outdoor environments.

Understanding which cats are most at risk matters for practical reasons. Veterinarians can use these risk profiles to decide when fecal screening is warranted, particularly in kittens presenting with diarrhea, and breeders and shelter operators can target their hygiene protocols toward the animals most likely to be shedding cysts. Routine testing of apparently healthy young cats, especially those entering new households from shelters or catteries, could reduce the introduction of the parasite into homes where other pets, or immunocompromised people, are present. Treatment typically involves antiprotozoal drugs such as fenbendazole or metronidazole, often combined with environmental decontamination and bathing to remove cysts from the coat and prevent reinfection.

The zoonotic dimension of the findings is where the study takes on its greatest public health significance. Giardia duodenalis is not a single homogeneous organism but an assemblage of genetically distinct lineages, conventionally labeled as assemblages A through H, each with characteristic host preferences. Assemblage A and assemblage B are the types most commonly associated with human giardiasis, while cats most frequently carry cat-adapted lineages such as assemblage F. The critical question for public health is how often cats carry the zoonotic assemblages capable of infecting people. The study’s title, which explicitly references zoonotic potential, indicates that the researchers addressed this question directly by examining which Giardia types were present in the sampled cats, and their results inform the ongoing debate over how much cats contribute to human giardiasis transmission.

Human giardiasis remains one of the most common intestinal parasitic diseases worldwide, causing an estimated hundreds of millions of infections globally each year. In developed countries, outbreaks are most often linked to contaminated drinking water or recreational water, and the role of pets as direct sources of human infection has long been considered limited, because many animal infections involve host-specific assemblages that do not readily infect humans. However, the possibility of zoonotic exchange has never been fully dismissed, and the high prevalence documented in pet cats means that even a small proportion of zoonotic infections in cats could translate into a meaningful, if modest, contribution to the overall burden of human disease. Standard hygiene practices, including handwashing after handling cats or cleaning litter boxes, remain the most effective safeguards.

For cat owners, the practical takeaways from the study are relatively straightforward. The one-in-twenty figure should not provoke alarm, since most infected cats either show no symptoms or respond well to treatment, and the parasite is readily killed by most disinfectants and by thorough drying of contaminated surfaces. Nevertheless, the findings argue for a low threshold for veterinary consultation when a cat, particularly a young one, develops persistent or recurrent diarrhea. Keeping cats indoors, maintaining clean litter boxes, preventing access to potentially contaminated water sources, and completing prescribed treatment courses all reduce transmission. For multi-cat households and catteries, where the parasite can circulate continuously among animals, systematic screening and hygiene management are especially valuable.

Scientifically, the study demonstrates the power of very large diagnostic datasets to resolve questions that smaller surveys could not. By aggregating results across a continent-spanning sample, the researchers produced prevalence estimates and risk-factor associations that are far more robust than those available previously, and they established a baseline against which future changes in Giardia epidemiology can be measured. As molecular typing methods become more widely applied to routine diagnostic samples, future work may clarify precisely what fraction of feline Giardia infections involve zoonotic assemblages, refining our understanding of the parasite’s movement between animal and human populations. In the meantime, the study provides veterinarians, public health officials, and cat owners across North America with the clearest picture yet of how common this persistent intestinal parasite is among the continent’s pet cats, and of which animals deserve the closest attention.

Subject of Research: Prevalence and zoonotic potential of Giardia duodenalis infection in domestic cats in the United States and Canada

Article Title: 1 in 20 pet cats in North America might have Giardia infection, with young, male, unneutered cats especially at risk, per analysis of more than 150,000 feline stool samples

Article References: 1 in 20 pet cats in North America might have Giardia infection, with young, male, unneutered cats especially at risk, per analysis of more than 150,000 feline stool samples. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Giardia duodenalis, domestic cats, parasitology, zoonosis, veterinary medicine, PLOS One, prevalence study, intestinal parasites, public health, kittens, fecal screening, North America

The research team, led by Michelle Larsen and including McKenna Willis, Valeria Scorza, Sangeeta Rao, and Michael Lappin from the Department of Clinical Sciences and the Center for Companion Animal Studies at Colorado State University, set out with a clear primary objective: to compare Giardia cyst detection results among several traditional fecal flotation techniques and an AI-enabled cyst assay, using fecal samples from shelter dogs with diarrhea. The traditional methods included zinc sulfate centrifugation with expert read, sugar centrifugation with expert read, and direct fluorescent antibody testing, known as DFA, also with expert read. The AI platform under evaluation was the Vetscan Imagyst system manufactured by Zoetis, which is designed for in-clinic use and can detect Giardia cysts in approximately ten minutes using machine-learning algorithms trained to recognize the distinctive morphology of the cysts in digitized images of fecal preparations.

The choice of comparator methods reflects the practical realities of veterinary diagnostics. Centrifugal fecal flotation remains the workhorse of most small animal clinics because it is inexpensive and requires only basic equipment, but its performance varies with the flotation solution used. Zinc sulfate centrifugation is widely regarded as one of the better flotation methods for recovering Giardia cysts, while sugar centrifugation is commonly used for the broader detection of gastrointestinal parasites. DFA, by contrast, uses fluorescently labeled antibodies that bind specifically to Giardia cysts, making it one of the most sensitive detection methods available, but it demands specialized fluorescence microscopy and trained personnel, which places it beyond the reach of most general practices. By anchoring the comparison to DFA and to expert-read flotation, the investigators created a benchmark that any point-of-care technology would have to approach closely to be considered clinically credible.

The study’s headline numbers are instructive. When DFA served as the reference standard, the AI-enabled Giardia cyst assay achieved a sensitivity of 71.4 percent and a specificity of 94.8 percent. Zinc sulfate centrifugation with expert read, measured against the same DFA benchmark, posted an identical sensitivity of 71.4 percent but a perfect specificity of 100 percent. When the two non-DFA methods were compared directly with each other, zinc sulfate centrifugation with expert read versus the AI-enabled cyst assay, the AI system delivered 80.0 percent sensitivity and 89.4 percent specificity. In other words, the machine-driven assay performed in roughly the same diagnostic territory as the expert-performed flotation technique that most clinics already rely on, and neither matched the analytic sensitivity of DFA, which detects cysts that both other methods can miss.

One of the most technically interesting parts of the study involved the use of polymerase chain reaction, or PCR, to adjudicate the discordant results. There were three samples that tested positive by DFA but negative by the AI-enabled Giardia cyst assay, and PCR confirmed that all three of these were genuinely false negatives on the AI side. Conversely, there were three samples that were negative by DFA but positive by the AI-enabled assay, and PCR confirmed that two of these were actually false negatives by DFA, meaning the AI system had correctly flagged infections that the antibody-based reference method had missed. This kind of molecular tie-breaking is a valuable feature of modern diagnostic studies, because it reveals that no single method is infallible and that apparent errors on one platform may in fact reflect limitations of the comparator rather than of the technology being tested.

The investigators also evaluated an AI-enabled fecal ova and oocyst assay, a broader screening mode intended to detect a range of gastrointestinal parasites rather than Giardia specifically, as a Giardia detection tool. This assay produced the lowest sensitivity for Giardia cysts among the methods tested, and the team concluded that it should not be used for Giardia detection, reserving that role for the dedicated Giardia cyst assay mode. The distinction matters operationally: the same imaging platform can run different algorithmic modes optimized for different targets, and the study demonstrates that performance characteristics do not necessarily transfer between modes. A general parasite screen that performs well for hookworm eggs or roundworm ova may not be tuned finely enough to catch Giardia cysts, which are smaller and morphologically subtler than many helminth eggs.

A secondary objective of the study used the same sample set to verify earlier published findings on other common gastrointestinal parasites, comparing AI-enabled parasite detection with sugar centrifugation read by experts. The results for detecting these other parasites, which include hookworms of the genus Ancylostoma, roundworms of the genus Toxocara, the whipworm Trichuris vulpis, and coccidian parasites of the genus Cystoisospora, were similar to those reported in prior studies. This replication is significant because it suggests that the earlier positive evaluations of AI-assisted fecal screening were not artifacts of a particular sample population or laboratory environment, but reflect a reproducible level of performance across different cohorts of diarrheic dogs.

From a veterinary practice standpoint, the implications are straightforward. Most small animal clinics do not employ a parasitology expert, and few have the fluorescence equipment needed to run DFA in house. Samples that require those capabilities are typically shipped to reference laboratories, adding days of delay during which an infected dog may continue to shed cysts into the environment and potentially infect other animals or, in the case of zoonotic concerns around Giardia, pose questions for the household. An AI-enabled system that returns a Giardia result in roughly ten minutes, with agreement comparable to expert centrifugal flotation, offers a way to move accurate parasitological diagnosis into the exam room, enabling same-visit treatment decisions and faster infection control in shelters, boarding facilities, and multi-dog households.

The authors conclude that the overall results from the three principal methods were similar, and they suggest that the AI-enabled Giardia cyst assay could be considered for use in small animal clinics for Giardia and other parasite detection, particularly in settings where a parasite expert or DFA testing is not routinely available. That framing is appropriately measured. The study does not claim that the AI system outperforms expert microscopy or DFA; rather, it demonstrates that the technology achieves clinically acceptable agreement with established methods while removing the dependence on scarce human expertise. For clinics that already have access to skilled microscopists and reference laboratory support, the traditional methods remain fully viable, and DFA retains its place as the most sensitive option when the clinical stakes demand maximal detection.

The study also illustrates the evolving relationship between commercial diagnostic developers and academic veterinary research. Zoetis provided the AI-enabled device and its supplies for the study, and the corresponding author, Michelle Larsen, is currently a full-time employee of Zoetis while completing a master’s program at Colorado State University; the company supplied the instruments but, according to the published declarations, did not influence study design, data analysis, or other portions of the research. Transparency about such arrangements is essential as AI diagnostics proliferate, and the open-access publication allows independent readers to scrutinize the sensitivity and specificity figures for themselves. As machine-learning diagnostic platforms continue to spread through veterinary medicine, studies of this kind, which benchmark them rigorously against expert-read traditional methods and use PCR to resolve discordant results, will be the standard against which their clinical adoption is judged.

Subject of Research: Comparison of AI-enabled and traditional diagnostic methods for detecting Giardia and other enteric parasites in diarrheic dogs

Article Title: Comparison of traditional and artificial intelligence methods for detection of enteric pathogens in feces of dogs with diarrhea

Article References: Larsen, M., Willis, M., Scorza, V., Rao, S., & Lappin, M. (2026). Comparison of traditional and artificial intelligence methods for detection of enteric pathogens in feces of dogs with diarrhea. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07685-7

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07685-7

Keywords: Giardia duodenalis, artificial intelligence, veterinary diagnostics, fecal flotation, direct fluorescent antibody, PCR, dogs, point-of-care testing, intestinal parasites, Parasites & Vectors, Colorado State University, diagnostic sensitivity